March 11, 2016
A Chinese drug company facing a $6 million claim over a botched note offering in New York federal court was given two weeks to find new lawyers on Friday after its efforts to force arbitration failed, despite concerns by an investor that the pharma company would use the time to hide its assets.
February 19, 2016
A month after a failed arbitration bid, attorneys with Dacheng Law Offices LLP have asked a New York federal judge for permission to withdraw as counsel for a Chinese herbal pharmaceuticals manufacturer in a $6 million lawsuit over a botched note offering, saying Friday they are no longer authorized to represent the company.
January 22, 2016
A Chinese herbal pharmaceuticals manufacturer that has been accused by investors in a $6 million lawsuit of breaching contracts in a $12 million financing offering lost its bid to arbitrate the investors' claims after a federal judge ruled Thursday that the parties had explicitly agreed to resolve all their disputes in New York courts.
December 07, 2015
Chinese herbal pharmaceuticals manufacturer Bohai Pharmaceuticals Group Inc. asked a New York federal judge Friday to force Euro Pacific Capital Inc.'s $6 million breach-of-contract suit into arbitration, saying an arbitration clause in an agreement the investment firm's allegations rely on is binding.
November 17, 2015
Investment firm Euro Pacific Capital Inc. on Monday moved to derail an herbal pharmaceuticals manufacturer's bid to force Chinese arbitration in a $6 million breach of contract battle, ripping its "misstatements of fact, overactive hyperbole and strained arguments."
June 08, 2015
Investors led by Westport, Connecticut-based investment firm Euro Pacific Capital Inc. have launched a $6 million lawsuit accusing Chinese herbal pharmaceuticals manufacturer Bohai Pharmaceuticals Group Inc. of breaching contracts and defaulting on an agreement over a $12 million financing offering by "going dark" and leaving investors on the hook.